Enabling a time-efficient workflow and better-informed clinical decision making for structural heart interventions GENT, Belgium–(BUSINESS WIRE)–FEops announced today its new release of FEops HEARTguide™, including an AI-based anatomical analysis of MSCT images for the pre-operative planning of structural heart interventions. […]
Tag: HeartGuide
FEops’ AI-enabled Solution Changes TAVI Pre-procedural Decision in One Third of Patients, Associated With Favorable Clinical Outcomes
GENT, Belgium–(BUSINESS WIRE)–Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguideTM result in an important change of pre-procedural decision making of the […]
FEops HEARTguide Receives FDA Clearance for LAAo Planning Capabilities
GENT, Belgium–(BUSINESS WIRE)–FEops today announced that it received authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion (LAAo) with the Abbott’s Amplatzer™ Amulet™ and Boston Scientific’s Watchman FLX™ device*. FEops HEARTguide […]
FEops HEARTguide Authorized by FDA for Unprecedented LAAo Planning Capabilities
GENT, Belgium–(BUSINESS WIRE)–FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion with the Boston Scientific WATCHMAN™ device*. FEops HEARTguide™ will enable physicians to […]
FEops HEARTGuide Combines Digital Twins and AI to Revolutionize Structural Heart Planning
GENT, Belgium–(BUSINESS WIRE)–FEops strengthens its position as the cloud-based digital health player in the structural heart space by introducing Artificial Intelligence into its CE marked FEops HEARTguide platform. FEops HEARTguide is a one-in-its-kind procedure planning platform for structural heart interventions that provides physicians with […]
FEops Announces 2.000 Patients Modelled With FEops HEARTguide™
GENT, Belgium–(BUSINESS WIRE)–FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions. FEops HEARTguide™ is currently commercially available […]
FEops Awarded Euro 3.2 Million Grant From EU
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, has been awarded a grant of Euro 3.2 million from the European Innovation Council (EIC) accelerator programme. “We are very proud to receive this grant, given the fierce competition. […]
HeartGuide™ from OMRON Healthcare Named to TIME’s List of the 100 Best Inventions of 2019
TIME recognizes HeartGuide™, the first wearable blood pressure monitor, as one of the groundbreaking inventions that are changing the way we live, work, play and think about what’s possible LAKE FOREST, Ill., Nov. 26, 2019 /PRNewswire/ — OMRON Healthcare, Inc., the global leader […]
FEops HEARTguideTM Wins CSI Highlight of the Year Award
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that FEops HEARTguideTM was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the category interventional […]
FEops HEARTguide™ Receives CE Mark
GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, today announced that FEops HEARTguideTM has received CE mark approval. FEops HEARTguideTM is a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning […]